Industry news

Viktor Vekselberg plans to spend $1B on new projects

Venture News

Viktor Vekselberg, the former co-owner of TNK-BP who received about $7B for his stake in the company, plans to invest part of the funds in its energy business (IES-Holding), and $1B in new projects in Russia, Bloomberg reports.
 

The revenue of Rusnano nanotech centers in 2012 is 365M RUR

Venture-news

According to Rusnano, the revenue of Russian nanotech centers that were launched in 2012 under the auspices of the Fund for infrastructure and educational programs of Rusnano, JSC totaled 365M RUR. 

U.S. struggles with pharmaceutical goals in Asia trade talks

Doug Palmer, Reuters

The United States is striving to find an appropriate balance in Asia-Pacific free trade talks between providing strong patent and data protections for U.S. drug manufacturers and ensuring poor people have access to medicine, a U.S. trade negotiator said on Thursday.

GlaxoSmithKline and Abbott to start production in Ukraine

The Pharma Letter

UK pharma giant GlaxoSmithKline and the USA’s Abbott are considering launching production of their drugs in Ukraine at the facilities of Indar, one of Ukraine’s largest pharmaceutical producers, owned by the state.

Eisai joins trend to enter Russian pharma market, with Halaven launch

The Pharma Letter

Japanese drug major Eisai unit, has announced it is expanding its operations by establishing a new sales and marketing operation in Russia, a market that has seen a great deal attention from multinational pharmaceutical companies in recent times.

Amendments to drug registration law in Russia: Implications for the future

Kavita Rainova, IHS Healthcare and Pharma blog

The eagerly awaited draft amendments to the federal law, as well as Article 333.32.1, part two of the tax code of the Russian Federation, were published for consultation by the country’s Ministry of Health in late January this year. The amendments proved to be a mixed bag.

Expert team publishes International Declaration after Open Innovations International Forum

The panel consisting of the well-known venture capitalists, managers of the world-leading universities, market analysts, and representatives of Russian development institutes prepared the International Declaration on the Forum "Open Innovation 2012".

Can Russia repeat last year’s GDP growth?

Viktor Kuzmin, Russia Beyond The Headlines

Russia led the G-8 and ranked second among BRICS countries in terms of economic growth rates in 2012. Experts make guesses whether Moscow will be able to replicate its performance in 2013.

Health Ministry Proposes Drug Registration System

The Moscow Times

The Health Ministry wants to create a database for controlling medicine sold in drug stores across the country.

Ukrainian government to simplify procedure for registration of imported drugs

The Pharma Letter

The government of Ukraine plans to simplify the procedure of registration of drugs, imported to the country from the European Union. According to an official representative of the Ukrainian State Drugs Service, all the companies, whose drugs are registered by the European Medicines Agency will pass the procedure for their registration in Ukraine only by filing a single application to the country’s Ministry of Health.